resisttb
- Sep 3
- 1 min read

Union welcomes EC authorization of TB Alliance’s BPaL treatment for drug-resistant TB

On August 3rd, a new treatment developed by the TB Alliance has been approved by the European Commission for some of the most drug-resistant forms of TB.

Learn more about the new Pretomanid drug here.

0 views

Recent Posts

Recent Webinar Slides!

Resist-TB recently hosted Dr. Dookie (Ph.D.) to speak about Individualised management of MDR and XDR-TB in South Africa using Whole Genome Sequencing. Watch the webinar recording here or access th

1Write a comment

COVID-19 Disruptions May Raise Cancer, HIV, TB Cases, Deaths Globally

Mounting evidence suggests the ongoing pandemic will have significant implications for the treatment and pathology of other burdensome diseases—tuberculosis included. Read about it here.

4Write a comment